ArticleInfectious diseases and therapy2022

Performance Evaluation of the Microfluidic Antigen LumiraDx SARS-CoV-2 and Flu A/B Test in Diagnosing COVID-19 and Influenza in Patients with Respiratory Symptoms.

Jayne E Ellis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.